BeStock  
Stocks › OLMA

Olema Pharmaceuticals OLMA

US equityMarket cap rank #3516
$7.94 +$0.02 (+0.25%)
Pre-market · Oct 8, 7:40 am ET · After hours $7.84 -1.32%
Open$7.90
Prev close$7.92
Day range$7.79 – $8.23
Volume819.5K
Market cap$694.73M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Community Sentiment on OLMA

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on OLMA.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

OLMA at a glance

OLMA is priced at $7.94 right now, up 0.25% on the session. That puts its market value at $694.73M, 3516th largest among the 3753 stocks we cover.

It is close to the bottom of its 52-week range ($6.65 to $36.26), 78.1% under the high. Holders are behind 26.0% over twelve months, and down 35.3% across the last three months.

On the chart it has slipped under both the 50-day ($10.24) and 200-day ($15.70) moving averages; RSI is 26, which some call oversold, and the last 30 sessions moved at roughly 46% annualized volatility.

Revenue for the quarter ended Jun 2026 was $0.00, and a net loss of $63.20M.

8 analysts follow the stock and the average call is "buy". The mean target, $33.17, sits 317.8% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3752 U.S. stocks BeStock covers.

D
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

8 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

OLMA is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2021-01-04, the strategy has returned 389% (231.1% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$33.17+317.8% vs. current price
Consensus ratingBuy8 analysts covering
Morningstar fair value$13.00Price is below fair value

Wall Street’s average 12-month target is $33.17, 317.8% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $13.00, so shares trade 38.9% below that estimate. On earnings multiple, it sits in the 51st percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+0.3%
1 week
-8.1%
1 month
-27.7%
3 months
-35.3%
6 months
-49.4%
Year to date
-68.2%
1 year
-26.0%
Day range
$7.79$8.23
52-week range
$6.65$36.26

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-13.1%Bearish
Price vs 50-day average-22.4%Bearish
Price vs 200-day average-49.4%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)25.6Neutral
MACD (12,26,9)-0.67Bearish
Bollinger band position15%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Key statistics

Bid / Ask$7.66 / $8.21
Average price today$8.06
Volume819.5KAvg (90d) 1.33M
Turnover$6.60M
Turnover rate1.38%of shares outstanding
Volume ratio0.72vs. recent average pace
Day amplitude5.56%
Market cap$694.73M
Float market cap$470.37M
Shares outstanding59.24M
EPS (TTM)-$1.87
P/B1.61
Book value / share$4.92
Earnings yield-0.43%
Net profit (TTM)-$163.62M
Net assets$430.58M
30-day volatility45.6%annualized
Avg daily range (ATR)5.82%of price, 14 days
Max drawdown (1y)-77.9%-77.8% from 1y peak

Quote as of Oct 8, 2026 7:40 am ET. Prices can lag the live tape. This is background information, not a recommendation.

How OLMA ranks on BeStock

Market value#3515 of 3752
Closeness to 52-week high#3707 of 3743
Dollar volume today#2533 of 3752

Ranks are among the 3,752 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

OLMA stock: common questions

How is Olema Pharmaceuticals stock doing today?

$7.94 is the latest print for OLMA, a move of +0.25% against yesterday's close of $7.92. Today's low and high so far: $7.79 and $8.23.

How large is Olema Pharmaceuticals by market value?

Equity value comes to $694.73M at the current price. By that measure it is number 3516 of the 3753 names in our coverage.

How far is OLMA from its yearly high?

The year's floor is $6.65 and the ceiling $36.26. Shares are 78.1% away from that ceiling.

Are there dividends on Olema Pharmaceuticals shares?

Our data shows no dividend paid by Olema Pharmaceuticals over the trailing twelve months.

What is the analyst view on Olema Pharmaceuticals?

Of 8 analysts, 100% say buy, 0% hold and 0% sell. Price targets average $33.17, with the most cautious at $16.00 and the most optimistic at $59.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on OLMA.

Leave a comment

Scroll to Top